178 related articles for article (PubMed ID: 11062805)
1. Are current recommendations for pneumococcal vaccination appropriate for Western Australia? The Vaccine Impact Surveillance Network--Invasive Pneumococcal Study Group.
Med J Aust; 2000 Oct; 173(S2):S36-40. PubMed ID: 11062805
[TBL] [Abstract][Full Text] [Related]
2. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
[TBL] [Abstract][Full Text] [Related]
3. Invasive pneumococcal disease in the Northern Territory of Australia, 1994-1998.
Krause VL; Reid SJ; Merianos A
Med J Aust; 2000 Oct; 173(S2):S27-31. PubMed ID: 11062803
[TBL] [Abstract][Full Text] [Related]
4. Invasive pneumococcal disease in Australia, 2006.
Roche PW; Krause V; Cook H; Barralet J; Coleman D; Sweeny A; Fielding J; Giele C; Gilmour R; Holland R; Kampen R; ; Brown M; Gilbert L; Hogg G; Murphy D;
Commun Dis Intell Q Rep; 2008 Mar; 32(1):18-30. PubMed ID: 18522302
[TBL] [Abstract][Full Text] [Related]
5. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
Lehmann D; Willis J; Moore HC; Giele C; Murphy D; Keil AD; Harrison C; Bayley K; Watson M; Richmond P
Clin Infect Dis; 2010 Jun; 50(11):1477-86. PubMed ID: 20420501
[TBL] [Abstract][Full Text] [Related]
6. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
7. Invasive pneumococcal disease in Australia, 2004.
Roche PW; Krause VL; Bartlett M; Coleman D; Cook H; Davis C; Fielding JE; Holland R; Giele C; Gilmour R; Kampen R; Brown M; Gilbert L; Hogg G; Murphy D;
Commun Dis Intell Q Rep; 2006; 30(1):80-92. PubMed ID: 16637236
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.
Jayasinghe S; Chiu C; Menzies R; Lehmann D; Cook H; Giele C; Krause V; McIntyre P
Vaccine; 2015 Nov; 33(48):6666-74. PubMed ID: 26519550
[TBL] [Abstract][Full Text] [Related]
9. Invasive pneumococcal disease in Australia 2007 and 2008.
Barry C; Krause VL; Cook HM; Menzies RI
Commun Dis Intell Q Rep; 2012 Jun; 36(2):E151-65. PubMed ID: 23186214
[TBL] [Abstract][Full Text] [Related]
10. Invasive pneumococcal disease in Australia, 2002.
Roche P; Krause V; Andrews R; Carter L; Coleman D; Cook H; Counahan M; Giele C; Gilmore R; Hart S; Pugh R; Hogg G; Murphy D; Watson M;
Commun Dis Intell Q Rep; 2003; 27(4):466-77. PubMed ID: 15508500
[TBL] [Abstract][Full Text] [Related]
11. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
12. The impact of the changing pneumococcal national immunisation program among older Australians.
Menzies R; Stein AN; Booy R; Van Buynder PG; Litt J; Cripps AW
Vaccine; 2021 Jan; 39(4):720-728. PubMed ID: 33384189
[TBL] [Abstract][Full Text] [Related]
13. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ;
Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450
[TBL] [Abstract][Full Text] [Related]
14. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
Johnson DR; D'Onise K; Holland RA; Raupach JC; Koehler AP
Vaccine; 2012 Mar; 30(12):2206-11. PubMed ID: 22273663
[TBL] [Abstract][Full Text] [Related]
16. Invasive pneumococcal disease in Australia, 2009 and 2010.
Bareja C; Toms C; Lodo K; de Kluyver R;
Commun Dis Intell Q Rep; 2015 Jun; 39(2):E265-79. PubMed ID: 26234260
[TBL] [Abstract][Full Text] [Related]
17. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ; McIntosh ED; Reinert RR
Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
[TBL] [Abstract][Full Text] [Related]
18. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK; Shea KM; Stevenson AE; Pelton SI;
Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
[TBL] [Abstract][Full Text] [Related]
19. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
